X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiac & cardiovascular systems (518) 518
index medicus (388) 388
humans (360) 360
male (269) 269
female (266) 266
aged (242) 242
abridged index medicus (210) 210
middle aged (204) 204
peripheral vascular disease (165) 165
treatment outcome (147) 147
risk factors (146) 146
atrial fibrillation (128) 128
stroke (127) 127
acute coronary syndromes (123) 123
heart attacks (116) 116
mortality (110) 110
double-blind method (101) 101
cardiovascular (92) 92
drug therapy (88) 88
clinical trials (85) 85
myocardial infarction (85) 85
clopidogrel (82) 82
outcomes (78) 78
follow-up studies (76) 76
medical and health sciences (76) 76
medicin och hälsovetenskap (76) 76
care and treatment (75) 75
anticoagulants (74) 74
risk (72) 72
hematology (67) 67
stroke - prevention & control (65) 65
warfarin (64) 64
time factors (63) 63
hemorrhage - chemically induced (62) 62
prognosis (62) 62
analysis (61) 61
cardiology (61) 61
electrocardiography (61) 61
platelet aggregation inhibitors - therapeutic use (61) 61
therapy (61) 61
anticoagulants - therapeutic use (59) 59
coronary heart disease (58) 58
prospective studies (58) 58
aged, 80 and over (56) 56
management (56) 56
atrial fibrillation - drug therapy (55) 55
myocardial-infarction (54) 54
patients (54) 54
cardiac patients (53) 53
cardiovascular disease (53) 53
clinical medicine (53) 53
atrial fibrillation - complications (52) 52
heart attack (52) 52
percutaneous coronary intervention (52) 52
acute coronary syndrome - drug therapy (51) 51
patient outcomes (51) 51
prevention (51) 51
stroke - etiology (51) 51
aspirin (50) 50
cardiac arrhythmia (50) 50
heart failure (49) 49
ischemia (46) 46
ticlopidine - analogs & derivatives (46) 46
klinisk medicin (45) 45
studies (45) 45
medicine, general & internal (44) 44
myocardial infarction - mortality (43) 43
platelet aggregation inhibitors - adverse effects (43) 43
unstable angina (43) 43
acute myocardial-infarction (42) 42
anticoagulants - administration & dosage (42) 42
cardiac and cardiovascular systems (42) 42
kardiologi (42) 42
proportional hazards models (42) 42
anticoagulants - adverse effects (41) 41
anticoagulation (41) 41
cardiology and cardiovascular medicine (41) 41
acute coronary syndrome (40) 40
cardiovascular diseases (40) 40
bleeding (39) 39
myocardial infarction - therapy (39) 39
randomized controlled trials as topic (39) 39
risk assessment (39) 39
rivaroxaban (39) 39
diabetes (37) 37
hemorrhage (37) 37
hospitalization (37) 37
incidence (37) 37
myocardial infarction - drug therapy (37) 37
coronary vessels (36) 36
registries (36) 36
clinical outcomes (35) 35
research (35) 35
safety (35) 35
medical research (34) 34
internal medicine (33) 33
thrombosis (33) 33
trial (33) 33
ticagrelor (32) 32
united states - epidemiology (32) 32
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 7, pp. 644 - 657
In this report of two randomized trials, patients with type 2 diabetes at risk for cardiovascular disease received the sodium–glucose cotransporter 2 inhibitor... 
MEDICINE, GENERAL & INTERNAL | METAANALYSIS | ATRIAL-NATRIURETIC-PEPTIDE | RATIONALE | INTENSIVE GLUCOSE CONTROL | PLACEBO-CONTROLLED TRIAL | OUTCOMES | INHIBITORS | STAGE KIDNEY-DISEASE | PROGRESSION | BASE-LINE CHARACTERISTICS | Hypoglycemic Agents - therapeutic use | Albuminuria - complications | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Hospitalization - statistics & numerical data | Kidney Diseases - mortality | Male | Canagliflozin - adverse effects | Disease Progression | Foot - surgery | Glomerular Filtration Rate - drug effects | Diabetes Mellitus, Type 2 - physiopathology | Canagliflozin - therapeutic use | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Aged | Amputation - statistics & numerical data | Kidney Diseases - etiology | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Type 2 diabetes | Heart | Complications and side effects | Care and treatment | Abnormalities | Amputation | Myocardial infarction | Heart attacks | Body weight | Clinical trials | Cardiovascular disease | Blood pressure | Drug dosages | Heart failure | Cerebral infarction | Stroke | Statistical analysis | Kidneys | Metatarsal | Diabetes mellitus | Toe | FDA approval | Glomerular filtration rate | Medicine | Studies | Side effects | Sodium | Diabetes | Kidney diseases | Cardiovascular diseases | Health risk assessment | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article
EUROPEAN HEART JOURNAL, ISSN 0195-668X, 01/2019, Volume 40, Issue 3, pp. 294 - 294
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2008, Volume 52, Issue 18, pp. 1502 - 1517
Journal Article
European Heart Journal, ISSN 0195-668X, 08/2018, Volume 39, Issue 32, pp. 2972 - 2974
Journal Article
Circulation, ISSN 0009-7322, 01/2018, Volume 137, Issue 4, pp. 323 - 334
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2012, Volume 367, Issue 26, pp. 2482 - 2494
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2017, Volume 376, Issue 1, pp. 32 - 40
In this randomized trial involving 13,885 patients with symptomatic peripheral artery disease (PAD), ticagrelor was not shown to be superior to clopidogrel for... 
PREVENTION | CONTROLLED-TRIAL | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR EVENTS | ASPIRIN | ATHEROTHROMBOTIC EVENTS | Double-Blind Method | Ticlopidine - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Intermittent Claudication - drug therapy | Middle Aged | Kaplan-Meier Estimate | Peripheral Arterial Disease - drug therapy | Male | Ticlopidine - analogs & derivatives | Ischemia - drug therapy | Leg - blood supply | Adenosine - adverse effects | Adenosine - analogs & derivatives | Adenosine - therapeutic use | Ticlopidine - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Platelet Aggregation Inhibitors - therapeutic use | Purinergic P2Y Receptor Antagonists - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Usage | Care and treatment | Clopidogrel | Diagnosis | Ticagrelor | Comparative analysis | Peripheral vascular diseases | Myocardial infarction | Cerebral infarction | Aspirin | Clinical trials | Vein & artery diseases | Bleeding | Clinical outcomes | Ankle | Vascular diseases | Ischemia | Arteriosclerosis | Comparative studies | Cardiovascular diseases | Drug therapy | Pharmaceuticals | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article